Predictors of treatment response to semaglutide for weight management
Ploutarchos Tzoulis · 2026
Read Predictors of treatment response to semaglutide for weight management by Ploutarchos Tzoulis (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13628350.txt.
Description
Ploutarchos Tzoulis reviews what predicts how much weight people lose on semaglutide, the weekly injectable drug that has reshaped obesity care. Weight loss on the drug varies widely between patients. This mini review gathers the current evidence on who responds best, so treatment can be matched to the person.
Having type 2 diabetes predicts notably less weight loss. Women lose more than men, by about six percent on average. A higher maintenance dose beats the standard dose by about three percent. Age and starting body mass show no clear link, though adolescence may help and mere overweight status may blunt the effect. Certain variants in the drug's target gene have a modest influence, and a 'hungry gut' obesity type may respond especially well. The type of lifestyle program alongside the drug seems not to matter. Tzoulis calls for validated prediction models to guide personal obesity care.
Catalog record
| CREATOR | Ploutarchos Tzoulis |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |